MULTIPHARMA held to be similar to MUNDIPHARMA
The EU General Court has reversed the EU Intellectual Property Office First Board of Appeal’s judgment that there was no likelihood of confusion between the marks MUNDIPHARMA and MULTIPHARMA based on conceptual differences.
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the WTR experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10